Skip to main content

Profusa, Inc.

corporate_fare Company Profile

Profusa, Inc.

PFSA·NASDAQ·Industrial Applications And Services·CIK 0001859807

Profusa, Inc. is a digital health technology company based in Berkeley, California. Originally incorporated as Northview Acquisition Corp., the company completed a business combination on July 11, 2025, and subsequently changed its name to Profusa, Inc. Over the last twelve years, Profusa has invested more than $100 million from venture investors and U.S. research institutions, including approximately $30 million from the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH). This investment has been used to develop a unique biosensor platform. This platform is designed to be easily injected subcutaneously, providing real-time, individual biochemistry in a cost-effective manner, and functions for more than six times longer than existing best-in-class solutions. Profusa's Lumee™ technology is a platform, not a single product, with the potential to launch products for multiple applications. The company's strategy has involved significant investment in developing and protecting its technology as a private company, initially focusing on Europe due to traditionally lower regulatory barriers compared to the U.S. Profusa has validated its technology and obtained CE approval in the European Union (EU) for its first product, Lumee Oxygen. The company is currently working to meet new Medical Device Regulation (MDR) requirements in Europe. In 2026, Profusa plans to launch Lumee Oxygen in the U.S., pending approval by the U.S. Food and Drug Administration (FDA), for sophisticated wound care management through a distribution partner. The accessible markets for Profusa's technology extend beyond the U.S. and the EU.

Profusa, Inc. (NASDAQ:PFSA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 73 items for PFSA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for PFSA spans 10-Q, PRE 14A, 8-K, DEF 14A.

Recent high-impact activity:

  • Profusa Q3 Loss Narrows to $4.95M; Cash Falls to $0.34M With Going Concern Doubt
  • Profusa Clears Key Hurdle for G3 Deal, Discloses $108M Target Revenue
  • Profusa Seeks Votes to Convert 3.31M Preferred Shares and Widen Reverse Split to 1-for-200
  • Profusa Cuts NorthView Note Conversion Floor to $0.20 From $1.07
  • Profusa Raises $700K Via $769K Ascent Convertible Note With 33% Offering Prepayment

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$35.82M
Diluted EPS
-$107.01
Op. Cash Flow
-$16.25M
Free Cash Flow
-$16.26M
Operating Income
-$27.71M
Cash & Equivalents
$1.78M
Total Debt
$7.88M
Debt / Equity
-0.30×
Shares Outstanding
1.23M sh
Source: 10-K · filed 2026-04-15 · accession 0001213900-26-044046

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 98,515 shares in PFSA as of the October 30, 2026 settlement, a 26.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 30.6% of PFSA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)98,515 shares as of October 30, 2026
Change vs prior period▲ 26.6%
Days to cover1.00 at avg daily volume of 4,312,750
Daily short volume (FINRA facilities)30.6% of 58,083 shares on November 20, 2026
5-day average short volume33.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for PFSA, detected from its recent SEC filings · based on capital-structure filings through 2026-11-06.

1 recent capital raisereverse split

Reverse Stock Split Effective · Significant Share Price Decline Post-Split

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with P →
$0.3242 +0.25% today
52-week range · as of 2026-11-13 $0.3242 – $1539.75
Market cap
$1.84M
Volume
164.5K (0.1× avg)
3-mo avg 2.1M
Live data · 2026-11-22 08:29 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PFSA - Latest Insights

PFSA
Nov 13, 2026, 3:55 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.44199
Real-time Price: $0.3242 info
Change: -$0.11779 (-27%) info
Market Cap: $1.838M info
PFSA
Nov 12, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7158
Real-time Price: $0.3242 info
Change: -$0.3916 (-55%) info
Market Cap: $1.838M info
PFSA
Nov 10, 2026, 5:09 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.5203
Real-time Price: $0.3242 info
Change: -$0.1961 (-38%) info
Market Cap: $1.838M info
PFSA
Nov 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.530
Real-time Price: $0.3242 info
Change: -$0.2058 (-39%) info
Market Cap: $1.838M info
PFSA
Oct 15, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $0.3242 info
Change: -$0.9358 (-74%) info
Market Cap: $1.838M info
PFSA
Oct 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $0.3242 info
Change: -$1.09 (-77%) info
Market Cap: $1.838M info
PFSA
Oct 05, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $0.3242 info
Change: -$1.42 (-81%) info
Market Cap: $1.838M info
PFSA
Sep 24, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $0.3242 info
Change: -$2.49 (-88%) info
Market Cap: $1.838M info
PFSA
Sep 16, 2026, 6:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.85
Real-time Price: $0.3242 info
Change: -$1.53 (-82%) info
Market Cap: $1.838M info
PFSA
Sep 15, 2026, 6:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.30
Real-time Price: $0.3242 info
Change: -$1.98 (-86%) info
Market Cap: $1.838M info
PFSA
Sep 01, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.02
Real-time Price: $0.3242 info
Change: -$2.70 (-89%) info
Market Cap: $1.838M info
PFSA
Aug 28, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $2.86
Real-time Price: $0.3242 info
Change: -$2.54 (-89%) info
Market Cap: $1.838M info
PFSA
Aug 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.41
Real-time Price: $0.3242 info
Change: -$5.09 (-94%) info
Market Cap: $1.838M info
PFSA
Aug 20, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.13
Real-time Price: $0.3242 info
Change: -$12.81 (-98%) info
Market Cap: $1.838M info
PFSA
Aug 20, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $13.10
Real-time Price: $0.3242 info
Change: -$12.78 (-98%) info
Market Cap: $1.838M info
PFSA
Aug 19, 2026, 8:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $13.10
Real-time Price: $0.3242 info
Change: -$12.78 (-98%) info
Market Cap: $1.838M info
PFSA
Aug 19, 2026, 8:14 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $13.10
Real-time Price: $0.3242 info
Change: -$12.78 (-98%) info
Market Cap: $1.838M info
PFSA
Aug 19, 2026, 8:13 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $13.10
Real-time Price: $0.3242 info
Change: -$12.78 (-98%) info
Market Cap: $1.838M info
PFSA
Aug 19, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $12.96
Real-time Price: $0.3242 info
Change: -$12.64 (-97%) info
Market Cap: $1.838M info
PFSA
Aug 18, 2026, 5:25 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $23.81
Real-time Price: $0.3242 info
Change: -$23.49 (-99%) info
Market Cap: $1.838M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets